platinum-resistant advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers.

1 total trials 1 recruiting

Filter these 1 trials by phase, country, sponsor and more.

Open in Search →

A study to evaluate dosing schedules of mirvetuximab soravtansine in patients with epithelial ovarian, primary peritoneal, or fallopian tube … Recruiting

2024-517184-23-00 4 2025-10-16

Showing 1–1 of 1 trials